Remdesivir shows modest benefits in coronavirus trial
Thursday, 30 April 2020 Modest results from a federal trial of an experimental drug helped send the stock market soaring on Wednesday, another sign of the desperation for a viable treatment against the coronavirus. Just before markets opened, Gilead, maker of the antiviral drug remdesivir, announced that it was “aware of positive data” about the drug’s performance in a […]
The first results of the experimental drug - remdesivir - shows that it has the ability to speed up recovery from coronavirus by 31%. Scientists say this is an important proof of concept that a drug can block this virus.